Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Freya Biosciences ApS
APS
Active
Advertising protection
CVR 41257547
Fruebjergvej 3, 2100
København Ø
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2020 · 6 years old
17 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Freya Biosciences ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
-1M
2020
0M
2021
-17M
2022
-5M
2023
-7M
2024
EBITDA
DKK millions
0M
-28M
-57M
-85M
-114M
-2M
2020
-23M
-1050%
2021
-39M
-70%
2022
-87M
-123%
2023
-91M
-5%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
-577
0
-16.628
-5.366
-6.657
Staff expenses
-873
-5.890
-7.155
-14.302
-18.999
EBITDA
-2.103
-22.635
-39.181
-87.196
-91.459
Depreciation & amort.
-15
-123
-123
-91
-90
EBIT
-2.118
-22.759
-39.304
-87.287
-91.549
Net financials
-35
-131
196
691
615
Profit before tax
-2.153
-22.889
-39.108
-86.596
-90.934
Tax
-258
-2.483
-6.951
-5.500
-5.500
Net profit
-1.895
-20.406
-32.157
-81.096
-85.434
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
17.194
32.367
16.376
81.766
141.431
Equity
16.761
28.411
-3.745
75.005
130.067
Long-term debt
0
0
13.014
0
0
Short-term debt
433
3.955
7.107
6.761
11.364
Total debt
433
3.955
20.121
6.761
11.364
Financial ratios
5-year trend
EBITDA margin
-9145923400.0%
This company
15.8%
Market median
-57885591239% vs market
2020
2024
Equity ratio
92.0%
This company
38.2%
Market median
+141% vs market
2020
2024
Return on equity
-65.7%
This company
18.4%
Market median
-457% vs market
2020
2024
Net profit margin
-8543429400.0%
This company
8.1%
Market median
-105474437137% vs market
2020
2024
Asset turnover
-0.05×
This company
1.12×
Market median
-104% vs market
2020
2024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-03-23 – 2020-12-31
View
PDF
More on Freya Biosciences ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
